| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
18,400,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Orchard Therapeutics is a holding company. Through its subsidiaries, Co. is a gene therapy company focused on the development of potentially curative gene therapies. Co.'s programs focused on neurodegenerative disorders consist of its commercial program approved in Europe, Libmeldy (OTL-200) for metachromatic leukodystrophy, two clinical proof of concept-stage programs, OTL-203 for mucopolysaccharidosis type I and OTL-201 for mucopolysaccharidosis type IIIA, and three preclinical programs, OTL-202 for mucopolysaccharidosis type IIIB, OTL-204 for frontotemporal dementia with progranulin mutations and OTL-205 for amyotrophic lateral sclerosis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rowland Charles A Jr |
|
– • – |
2024-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,294) |
0 |
|
- |
|
| Gaspar Bobby |
Chief Executive Officer |
• • – |
2024-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(366,158) |
0 |
|
- |
|
| Geraghty James A |
|
– • – |
2024-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(44,391) |
0 |
|
- |
|
| Beck Joanne T. |
|
– • – |
2024-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,294) |
0 |
|
- |
|
| Dunoyer Marc |
|
– • – |
2024-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(37,179) |
0 |
|
- |
|
| Thomas Frank E |
See Remarks |
• – – |
2024-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(92,081) |
0 |
|
- |
|
| Thomas Frank E |
See Remarks |
• – – |
2023-03-10 |
4 |
OE |
$0.46 |
$9,182 |
D/D |
20,000 |
92,081 |
|
- |
|
| Thomas Frank E |
See Remarks |
• – – |
2023-02-09 |
4 |
OE |
$0.46 |
$9,182 |
D/D |
20,000 |
72,081 |
|
- |
|
| Gaspar Bobby |
Chief Executive Officer |
• • – |
2022-04-01 |
4 |
B |
$0.74 |
$11,085 |
D/D |
15,000 |
366,158 |
2.81 |
- |
|
| Thomas Frank E |
See Remarks |
• – – |
2022-04-01 |
4 |
B |
$0.75 |
$7,474 |
D/D |
10,000 |
52,081 |
2.74 |
- |
|
| Fmr Corp |
See Remark 1 |
– – • |
2021-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
819,704 |
4,099,540 |
|
- |
|
| Fmr Corp |
See Remark 1 |
– – • |
2021-02-05 |
4 |
S |
$6.98 |
$14,277,660 |
I/I |
(2,045,510) |
5,099,540 |
|
- |
|
| Thomas Frank E |
See Remarks |
• – – |
2021-01-29 |
4 |
OE |
$2.44 |
$24,400 |
D/D |
10,000 |
42,081 |
|
- |
|
| Thomas Frank E |
See Remarks |
• – – |
2021-01-11 |
4 |
D |
$6.72 |
$24,904 |
D/D |
(3,706) |
32,081 |
|
- |
|
| Gaspar Bobby |
Chief Executive Officer |
• • – |
2021-01-11 |
4 |
D |
$6.72 |
$22,922 |
D/D |
(3,411) |
351,158 |
|
- |
|
| Thomas Frank E |
See Remarks |
• – – |
2021-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,667 |
35,787 |
|
- |
|
| Gaspar Bobby |
Chief Executive Officer |
• • – |
2021-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
354,569 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-09-24 |
4 |
B |
$4.61 |
$2,182,037 |
I/I |
473,327 |
9,880,865 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-08-21 |
4 |
B |
$4.51 |
$298,610 |
I/I |
64,642 |
9,407,538 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-08-20 |
4 |
B |
$4.61 |
$288,729 |
I/I |
62,631 |
9,342,896 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-08-19 |
4 |
B |
$4.65 |
$300,989 |
I/I |
64,254 |
9,280,265 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-08-18 |
4 |
B |
$4.72 |
$213,575 |
I/I |
45,249 |
9,216,011 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-08-17 |
4 |
B |
$4.74 |
$39,034 |
I/I |
8,235 |
9,170,762 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-08-14 |
4 |
B |
$4.74 |
$61,767 |
I/I |
13,031 |
9,162,527 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-08-12 |
4 |
B |
$4.74 |
$77,219 |
I/I |
16,291 |
9,149,496 |
1.5 |
- |
|
43 Records found
|
|
Page 1 of 2 |
|
|
